Chief Operating Officer · Ventyx Biosciences, Inc. (VTYX)

Matthew Moore

FY2024 is the first fiscal year CompBrief holds for Matthew Moore as a named executive officer of Ventyx Biosciences; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Velarion Intel: free for 3 days, no card →

Total disclosed compensation, FY2024

$1,918,110

1st of 4 named executive officers at Ventyx Biosciences by FY2024 total.

4 named officers on file for Ventyx Biosciences, FY2024

See an example →

What this number hides

The filing gives the total. Ventyx Biosciences’s full Executive Compensation Report gives every award, the disclosed peer set and what the total leaves out — the pair adds the board’s.

Velarion Intel · free for 3 days · no card

See how Ventyx Biosciences’s whole pay program stands against its peers

  • Ventyx Biosciences’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on VTYX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 23, 2025 (DEF 14A).

Free

Get Matthew Moore’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Matthew Moore and every company like it: Velarion Intel, free for 3 days, no card →

Matthew Moore compensation by year

Ventyx Biosciences Summary Compensation Table · the one fiscal year held
In US dollars, as Ventyx Biosciences reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024
Salary$296,875
Bonus$0
Stock awards$0
Option awards$1,305,600
Non-equity incentive$190,000
Pension and deferred compensation$0
All other$125,635
Total$1,918,110

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Ventyx Biosciences, Inc. DEF 14A filed April 23, 2025, accession 0000950170-25-057384, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Ventyx Biosciences, Inc. filed document, accession 0000950170-25-057384. Every figure is read from that document and cited to the page and table it appears in. Filed April 23, 2025.

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
Option320,000—$4.98

Per the Outstanding Equity Awards at Fiscal Year-End table in Ventyx Biosciences, Inc.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.

Ventyx Biosciences’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Matthew Moore · this pageChief Operating Officer$1,918,110
Raju MohanChief Executive Officer, President and Director$1,283,015
Martin AusterFormer Chief Financial Officer$995,179
Mark FormanChief Medical Officer$937,465

Matthew Moore's compensation dossier, Ventyx Biosciences

You have read Matthew Moore's totals and holdings. The dossier adds each equity grant Ventyx Biosciences disclosed for Matthew Moore and Ventyx Biosciences's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.

See an example →

The full Ventyx Biosciences compensation record

free company brief

This page is one person within Ventyx Biosciences's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Ventyx Biosciences's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Ventyx Biosciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Order VTYX

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Matthew Moore's compensation dossier